Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor David Jones

Newcastle AuthorsTitleYearFull text
Dr George Mells
Professor David Jones
Professor James Wason
Shaun Hiu
Dorcas Kareithi
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls2025
Dr Jess Dyson
Professor David Jones
Dr George Mells
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis2025
Dr Aaron Wetten
Dr Jess Dyson
Professor David Jones
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?2024
Professor David Jones
Assessment of fatigue and its impact in chronic liver disease2024
Professor David Jones
Dr George Mells
Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery2024
Dr Aaron Wetten
Dr Jess Dyson
Professor David Jones
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis2024
Professor David Jones
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis2024
Colette Kirk
Professor John Mathers
Professor Mark Pearce
Dr Nicholas Thompson
Professor David Jones
Factors that impact on the quality of life of intestinal failure patients treated with home parenteral nutrition: protocol for a multicentre, longitudinal observational study2024
Professor David Jones
Golexanolone improves fatigue, motor incoordination and gait and memory in rats with bile duct ligation2024
Professor David Jones
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis2024
Professor David Jones
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry2024
Dr Jess Leighton
Professor David Jones
Dr Jess Dyson
Professor Heather Cordell
Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis2024
Professor David Jones
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis2024
Professor David Jones
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply2024
Professor David Jones
Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial2024
1234567891011121314151617181920...>>